Stewart TJ - Search Results

1

The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signaling.

Verbrugge I, Gasparini A, Haynes NM, Hagekyriakou J, Galli M, Stewart TJ, Abrams SI, Yagita H, Verheij M, Johnstone RW, Borst J, Neefjes J. Verbrugge I, et al. Among authors: stewart tj. Radiat Res. 2014 Aug;182(2):219-29. doi: 10.1667/RR13511.1. Epub 2014 Jun 24. Radiat Res. 2014. PMID: 24960417

2

How tumours escape mass destruction.

Stewart TJ, Abrams SI. Stewart TJ, et al. Oncogene. 2008 Oct 6;27(45):5894-903. doi: 10.1038/onc.2008.268. Oncogene. 2008. PMID: 18836470 Review.

3

Host immunosurveillance controls tumor growth via IFN regulatory factor-8 dependent mechanisms.

Greeneltch KM, Schneider M, Steinberg SM, Liewehr DJ, Stewart TJ, Liu K, Abrams SI. Greeneltch KM, et al. Among authors: stewart tj. Cancer Res. 2007 Nov 1;67(21):10406-16. doi: 10.1158/0008-5472.CAN-07-1228. Cancer Res. 2007. PMID: 17974984 Free article.

4

Immune consequences of protracted host-tumor interactions in a transgenic mouse model of mammary carcinoma.

Stewart TJ, Lutsiak ME, Abrams SI. Stewart TJ, et al. Cancer Invest. 2008 Apr-May;26(3):237-49. doi: 10.1080/07357900701708419. Cancer Invest. 2008. PMID: 18317964 Free article.

5

Altered immune function during long-term host-tumor interactions can be modulated to retard autochthonous neoplastic growth.

Stewart TJ, Abrams SI. Stewart TJ, et al. J Immunol. 2007 Sep 1;179(5):2851-9. doi: 10.4049/jimmunol.179.5.2851. J Immunol. 2007. PMID: 17709499

6

Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells.

Stewart TJ, Liewehr DJ, Steinberg SM, Greeneltch KM, Abrams SI. Stewart TJ, et al. J Immunol. 2009 Jul 1;183(1):117-28. doi: 10.4049/jimmunol.0804132. J Immunol. 2009. PMID: 19542426 Free PMC article.

7

Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells.

Stewart TJ, Greeneltch KM, Reid JE, Liewehr DJ, Steinberg SM, Liu K, Abrams SI. Stewart TJ, et al. J Cell Mol Med. 2009 Sep;13(9B):3939-50. doi: 10.1111/j.1582-4934.2009.00685.x. J Cell Mol Med. 2009. PMID: 20196788 Free PMC article.

8

Immunological responses can have both pro- and antitumour effects: implications for immunotherapy.

Stewart TJ, Greeneltch KM, Lutsiak ME, Abrams SI. Stewart TJ, et al. Expert Rev Mol Med. 2007 Feb 7;9(4):1-20. doi: 10.1017/S1462399407000233. Expert Rev Mol Med. 2007. PMID: 17284328 Review.

9

CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.

Nesterova MV, Johnson NR, Stewart T, Abrams S, Cho-Chung YS. Nesterova MV, et al. Clin Cancer Res. 2005 Aug 15;11(16):5950-5. doi: 10.1158/1078-0432.CCR-05-0624. Clin Cancer Res. 2005. PMID: 16115938

10

Downregulation of IFN-gammaR in association with loss of Fas function is linked to tumor progression.

Yang D, Stewart TJ, Smith KK, Georgi D, Abrams SI, Liu K. Yang D, et al. Among authors: stewart tj. Int J Cancer. 2008 Jan 15;122(2):350-62. doi: 10.1002/ijc.23090. Int J Cancer. 2008. PMID: 17918178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters